Filed before 2025Filed 21 February 2024
Flagship Biosciences, Inc. has sold $3M so far
Flagship Biosciences, Inc., a biotech company based in Broomfield, CO, has sold $3M so far in its convertible round, according to a filing dated 21 February 2024.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 21 February 2024
- First filed
- 14 December 2023
- Round
- Convertible round (amended filing)
- Amount sold
- $3M
- Offering size
- $5M
- Investors so far
- 3
- Based in
- Broomfield, CO
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 26% of the 1,434 tracked raises with an amount filed in 2024, and than 15% of the 138 in biotech.
Flagship Biosciences, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 18 Apr 2024 | New filing | $5M | Another raise |
| 21 Feb 2024 | Amended filing | $3M | This raise |
| 14 Dec 2023 | New filing | $1.5M | This raise |
More with BroadOak Capital on the board
- Biolog, Inc. /DE/$16.1M
- LTS1, Inc.$2.5M
- Telesis Bio Inc.$28M
- Optofluidics, Inc.$7M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.